Relative Bioavailability Study of Succinic Acid Cocrystal Tablet and Marketed Conventional Immediate Release Tablet Formulation of Carbamazepine 200 Mg in Rabbits
Ullah, M.; Murtaza, G.; Hussain, I.
Acta Poloniae Pharmaceutica 73(5): 1412
2016
ISSN/ISBN: 0001-6837
PMID: 29638084
Accession: 065472887
PDF emailed within 1 workday: $29.90
Related References
Lücker, P.W.; Wetzelsberger, N.; Schettler, T.; Rogalla, K. 1992: Pharmacokinetics and relative bioavailability of a new chewable, buffered acetylsalicylic acid tablet formulation in comparison to a conventional plain tablet Methods and Findings in Experimental and Clinical Pharmacology 14(10): 805-811Bass, A.; Stark, J.G.; Pixton, G.C.; Sommerville, K.W.; Zamora, C.A.; Leibowitz, M.; Rolleri, R. 2012: Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers Clinical Therapeutics 34(7): 1601-1612
Ullah, M.; Hussain, I.; Sun, C.C. 2016: The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance Drug Development and Industrial Pharmacy 42(6): 969-976
Yamashita, H.; Sun, C.C. 2020: Material-Sparing and Expedited Development of a Tablet Formulation of Carbamazepine Glutaric Acid Cocrystal- a QbD Approach Pharmaceutical Research 37(8): 153
E.S.attawy, H.; Kassem, A.; Zaghloul, A. 1997: Comparative kinetics and bioavailability of bioadhesives containing or not-containing ketoprofen tablet formulations relative to conventional tablet in humans Pharmaceutical Research (New York) 14(11 Suppl): S249
Ahmed, I.S.; Fatahalla, F.A. 2007: Pilot study of relative bioavailability of two oral formulations of ketoprofen 25 mg in healthy subjects. A fast-dissolving lyophilized tablet as compared to immediate release tablet Drug Development and Industrial Pharmacy 33(5): 505-511
Scheidel, B.; Maritz, M.A.; Gschwind, Y.J.; Steigerwald, K.; Guth, V.; Kovacs, P.; Rey, H. 2017: Bioavailability of oxycodone after administration of a new prolonged-release once-daily tablet formulation in healthy subjects, in comparison to an established twice-daily tablet International Journal of Clinical Pharmacology and Therapeutics 55(11): 881-890
Borges, N; Mendes, G; Denucci, G 2006: PIII-80Bioequivalence study comparing carvedilol formulation from (tablet 25 mg) with a marketed reference (tablet 25 mg) in healthy volunteers Clinical Pharmacology and Therapeutics 79(2): P81-P81
Yamashita, H.; Sun, C.Calvin. 2019: Expedited Tablet Formulation Development of a Highly Soluble Carbamazepine Cocrystal Enabled by Precipitation Inhibition in Diffusion Layer Pharmaceutical Research 36(6): 90
Iman Saad, A.H.M.E.D.; Mona Hassan, A.B.O.U.L.E.I.N.I.E.N.; Osama Hussein, M.O.H.A.M.E.D.; Samar Farghali, F.A.R.I.D. 2008: Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet : A single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states European Journal of Pharmaceutical Sciences 35(3): 219-225
Ahmed, I.S.; Aboul-Einien, M.H.; Mohamed, O.H.; Farid, S.F. 2008: Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 35(3): 219-225
Bende, G.; Biswal, S.; Bhad, P.; Chen, Y.; Salunke, A.; Winter, S.; Wagner, R.; Sunkara, G. 2016: Relative bioavailability of diclofenac potassium from softgel capsule versus powder for oral solution and immediate-release tablet formulation Clinical Pharmacology in Drug Development 5(1): 76-82
Abbas, R.; Palumbo, D.; Walters, F.; Belden, H.; Berry, S.A. 2016: Single-dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-release Chewable Tablet Compared with Immediate-release Methylphenidate Chewable Tablet Clinical Therapeutics 38(5): 1151-1157
Maas, B.; Garnett, W.R.; Pellock, J.M.; Comstock, T.J. 1987: A comparative bioavailability study of carbamazepine tablets and a chewable tablet formulation Therapeutic Drug Monitoring 9(1): 28-33
Kakuda, T.N.; Leopold, L.; Timmers, M.; Van De Casteele, T.; Hillewaert, V.; Tomaka, F.L.; Hoetelmans, R.M.W. 2014: Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation International Journal of Clinical Pharmacology and Therapeutics 52(9): 805-816
Maas, B.; Garnett, W.R.; Comstock, T.J.; Pellock, J.M. 1985: Comparison of the relative bioavailability and pharmacokinetics of carbamazepine tablets and chewable tablet formulations Annals of Neurology 18(3): 379
Sidharta, P.N.; Štěpánová, R.; Globig, S.; Ulč, I.; Csonka, D.én. 2020: Relative bioavailability of a pediatric dispersible tablet and adult film-coated tablet of macitentan in healthy volunteers Pharmacology Research and Perspectives 8(2): E00580
Zhong, D.; Huang, H.; Wang, A.; Tian, L.; Lei, X.; Zhang, J. 1998: Comparison of roxithromycin bioavailability of a conventional and a dispersible tablet formulation Yao Xue Xue Bao 33(8): 621-625
Essigman, W.; Lambert, J.; Sheldon, P.; Sweetman, B.J.; Wojtulewski, J. 1987: A comparison of a sustained release preparation of tiaprofenic acid with the conventional tablet formulation and a placebo in rheumatoid arthritis International Journal of Clinical Pharmacology Research 7(4): 251-257
Buchanan, A.M.; Holton, M.; Conn, I.; Davies, M.; Choukour, M.; Wynne, B.R. 2017: Relative Bioavailability of a Dolutegravir Dispersible Tablet and the Effects of Low- and High-Mineral-Content Water on the Tablet in Healthy Adults Clinical Pharmacology in Drug Development 6(6): 577-583